| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Sale | -$3.11M | -14.6K | -0.25% | $213.26 | 5.87M | Nov 24, 2021 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Sale | -$3.18M | -15.1K | -0.26% | $210.99 | 5.85M | Nov 26, 2021 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.25 to $214.86. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $214.27. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |